Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

CD52 expression on CD4+ T cells in HIV-positive individuals on cART

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Vitamin D levels and Cancer Incidence in 217.244 individuals from Primary Health Care in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Torque-Teno virus viral load as a potential endogenous marker of immune function in solid organ transplantation

    Research output: Contribution to journalReviewResearchpeer-review

  3. Diagnosing von Willebrand disease

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Human immune defect virus (HIV) persists in a latent state in quiescent CD4+ T cells preventing eradication of HIV. CD52 is a surface molecule modulated by HIV. We aimed at examining factors related to CD52 expression on CD4+ T cells in HIV-positive individuals and the impact of initiation of combination antiretroviral therapy (cART).

METHODS: Peripheral blood mononuclear cells (PBMC) from 18 HIV-positive individuals and 10 uninfected age and gender matched controls were examined by flow cytometry for CD38 and CD52 expression on CD4+ T cells. Stimulation assays were performed on 8 healthy blood donors to determine a cut-off for CD52 expression.

RESULTS: All examined CD4+ T cells expressed CD52. However, both CD4+ T cells with higher (CD52++) and with lower CD52 expression (CD52dim) were found in HIV-positive individuals compared to uninfected controls. Two % CD52dim cells defined groups of high and low CD52: The group of individuals with high CD52 had higher CD4 counts at baseline (447 vs. 54 cells/µL, p=0.02) and higher increase of CD4 counts during follow-up compared to low CD52 (p=0.02). After 12 months of cART CD52 increased (MFI 4846 vs.5621, p<0.05), while CD38 decreased (MFI 1519 vs. 730, p<0.0001).

CONCLUSIONS: All HIV-positive individuals in this cohort had CD4+ T cells that expressed CD52. Higher CD4 counts were found in those with high CD52. Furthermore, an increase in CD52 was found after 12 months of cART, indicating that anti-CD52 antibodies may be more efficient for depletion of CD4+ T cells in HIV-positive individuals on cART.

Original languageEnglish
JournalJournal of acquired immune deficiency syndromes (1999)
Volume77
Issue number2
Pages (from-to)217-220
Number of pages4
ISSN1525-4135
DOIs
Publication statusPublished - 1 Feb 2018

    Research areas

  • Journal Article

ID: 52213939